drovelis
gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - Полови хормони и слиза на половата система, - oral contraceptive.
lydisilka
estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - Полови хормони и слиза на половата система, - Устна контрацепция. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.
velgin 3 mg/0,02 mg film - coated tablets
exeltis magyarorszag kft., - Дроспиренон и естроген - 3 mg/0,02 mg film - coated tablets
yasmin 0,03 mg/3 mg film - coated tablets
bayer pharma ag - Дроспиренон и естроген - 0,03 mg/3 mg film - coated tablets
cleodette 0,02 mg/3 mg film - coated tablets
actavis group ptc ehf. - Дроспиренон и естроген - 0,02 mg/3 mg film - coated tablets
cleosensa 0,03 mg/3 mg film - coated tablets
actavis group ptc ehf. - Дроспиренон и естроген - 0,03 mg/3 mg film - coated tablets
cleonita 0,02 mg/3 mg film-coated tablets
actavis group ptc ehf. - Дроспиренон и естроген - 0,02 mg/3 mg film-coated tablets
tybost
gilead sciences ireland uc - cobicistat - ХИВ инфекции - Антивирусни средства за системно приложение - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
evotaz
bristol-myers squibb pharma eeig - cobicistat, atazanavir - ХИВ инфекции - Антивирусни средства за системно приложение - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 и 5.
genvoya
gilead sciences ireland uc - элвитегравир, кобицистат, emtricitabine, tenofovir alafenamide - ХИВ инфекции - Антивирусни средства за системно приложение - genvoya е показан за лечение на възрастни и юноши (на възраст 12 години и повече с тяло тегло най-малко 35 кг), заразени с човешкия имунодефицитен вирус (hiv 1) 1 без никакви известни мутации, свързани с резистентност към интеграза инхибитор клас, emtricitabine или tenofovir.